Core Viewpoint - A class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (NASDAQ: INO) for allegedly issuing materially false and misleading statements regarding its manufacturing processes and regulatory prospects for its lead product candidate, INO-3107 [1]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from October 10, 2023, to December 26, 2025, Inovio's manufacturing for its CELLECTRA device was deficient [1]. - It is claimed that Inovio was unlikely to submit its lead product candidate, INO-3107 Biologics License Application (BLA), to the FDA by the second half of 2024 [1]. - The company allegedly lacked sufficient information to justify INO-3107's eligibility for FDA accelerated approval or priority review [1]. - Consequently, the overall regulatory and commercial prospects of INO-3107 were overstated [1]. - As a result, the public statements made by the defendants were materially false and misleading throughout the relevant period [1]. Next Steps for Shareholders - Shareholders who purchased shares of INO during the specified timeframe are encouraged to register for the class action, with a deadline of April 7, 2026, to seek lead plaintiff status [1]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [1]. - Participation in the case incurs no cost or obligation for the shareholders [1]. Law Firm Information - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders and aims to protect the rights of investors who have suffered due to deceit and fraud [1]. - The firm emphasizes its commitment to ensuring responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of the company's stock [1].

Group 1 - Caterpillar Inc. CEO Joe Creed and Group President Rod Shurman will participate in a fireside chat at CONEXPO in Las Vegas on March 5, 2026 [1] - The event will be hosted by Steve Volkmann of Jefferies and will start at approximately 8:00 a.m. PST [1] - A real-time video webcast will be available to the public, and a transcript, audio, and video will be posted on Caterpillar's investor relations website afterward [1] Group 2 - Caterpillar reported sales and revenues of $67.6 billion for the year 2025, establishing itself as a leading manufacturer in construction and mining equipment [1] - The company operates through primary business segments including Power & Energy, Construction Industries, and Resource Industries, focusing on solving customer challenges through advanced technology [1] - Caterpillar is supported by one of the largest independent global dealer networks and financing services through Cat Financial [1]

Core Insights - The Clorox Company has released a report titled "Home Care Redefined," which explores the evolving landscape of consumer home care, emphasizing the importance of time, wellness, and convenience in home management [1] Group 1: Time at Home - Americans are now integrating quick, purposeful cleaning moments throughout their day, rather than dedicating large blocks of time to chores [1] - On average, Americans spend 5.6 hours per week cleaning, an increase from 5 hours in 2016, with parents and pet owners showing a more pronounced increase in cleaning frequency [1] Group 2: Wellness at Home - Consumers are increasingly prioritizing their well-being, viewing cleaning as a means to enhance mental health and find control in a volatile world [1] - 60% of Americans consider cleaning a way to boost their mood and confidence, indicating a shift from purely functional outcomes to emotional and social factors [1] Group 3: Convenience at Home - Convenience is now defined by ease and enjoyment rather than speed, with 74% of consumers preferring multi-purpose cleaners over specialized ones [1] - Gen Z is influencing the narrative around everyday tasks, turning them into enjoyable experiences rather than mere chores [1] Group 4: Health and Environment - There is a growing awareness of how home environments affect health, with 89% of consumers managing their air quality at least weekly [1] - 89% of individuals believe a clean-smelling home enhances their self-image, with younger consumers seeking solutions that improve their home environment [1] Group 5: Future Implications - The report suggests that as consumer relationships with their homes evolve, companies must innovate to meet health, convenience, and well-being needs, emphasizing seamless shopping experiences and product innovation [1]

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against BlackRock TCP Capital Corp. (NASDAQ: TCPC) for allegedly issuing misleading statements regarding the company's investments and financial health during the class period from November 6, 2024, to January 23, 2026 [1]. Group 1: Allegations - The complaint alleges that TCPC's investments were not being timely or appropriately valued [1]. - It is claimed that the company's portfolio restructuring efforts were ineffective in resolving challenged credits or improving portfolio quality [1]. - The lawsuit asserts that TCPC's unrealized losses were understated, leading to an overstated net asset value [1]. - As a result of these issues, the positive statements made by the defendants about the company's business and prospects were materially misleading [1]. Group 2: Class Action Details - Shareholders who purchased TCPC shares during the specified class period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1]. - The deadline for shareholders to register for the class action is April 6, 2026 [1]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [1].

Picard Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PMI [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Picard Medical, Inc. (NYSE: PMI).Shareholders who purchased shares of PMI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to ...

Shareholders of Varonis Systems, Inc. Should Contact The Gross Law Firm Before March 9, 2026 to Discuss Your Rights - VRNS [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Varonis Systems, Inc. (NASDAQ: VRNS).Shareholders who purchased shares of VRNS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to p ...

Core Insights - Bon Natural Life Limited has developed a premium anti-aging facial mask that utilizes apple polyphenols and AI-enabled bio-electronic technology, targeting the $100 billion medical aesthetics market [1] Company Developments - The mask incorporates apple polyphenols, which are known for their antioxidant, anti-inflammatory, and photoprotective properties, and aims to improve skin firmness, brightness, and overall appearance [1] - Initial internal evaluations of the mask have shown performance indicators exceeding benchmarks, including improvements in fine lines, skin firmness, and UV-related skin stress [1] - The company plans to initiate third-party clinical testing and optimize large-scale manufacturing processes for the product [1] Market Positioning - The global anti-aging market has surpassed $100 billion, with premium transdermal delivery devices being one of the fastest-growing segments [1] - By combining apple polyphenols with bio-electronic technology, the company aims to establish a first-mover advantage in this emerging premium segment [1] - The CEO emphasized that the product is driven by technology and market demand, aiming to create a second growth engine characterized by strong pricing power and high repurchase potential [1]

Core Viewpoint - Generac Holdings Inc. has signed a definitive agreement to acquire Enercon Engineering, Inc., enhancing its capabilities in the data center and switchgear markets to meet the increasing demand for backup power solutions as global data center capacity is projected to more than triple by 2030 [1] Company Overview - Generac is a leading global designer, manufacturer, and provider of energy technology solutions, founded in 1959, with a focus on power generation equipment and energy management solutions [1] - Enercon, established in 1975, specializes in custom power equipment and industrial enclosures, operating a 160,000-square-foot manufacturing facility in East Peoria, Illinois [1] Acquisition Details - The acquisition of Enercon will allow Generac to leverage Enercon's 50 years of expertise in custom power systems, enhancing its Commercial & Industrial (C&I) business [1] - Enercon will operate as "Enercon, a Generac company" under Generac's Domestic Commercial & Industrial Business Group, with its current leadership team remaining in place [1] - The closing of the acquisition is subject to regulatory approvals and is expected in the second quarter of 2026 [1] Market Context - The demand for backup power generators in the data center market is anticipated to be a significant driver of growth for Generac, as the company aims to double its C&I product sales in the coming years [1] - Generac's investment in scaling its manufacturing capacity is part of a broader strategy to meet the growing needs of hyperscale and enterprise data center markets, where reliability and precision are critical [1]

Shareholders that lost money on Vistagen Therapeutics, Inc.(VTGN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Vistagen Therapeutics, Inc. (NASDAQ: VTGN).Shareholders who purchased shares of VTGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff i ...

Core Insights - eHealth has announced a new growth strategy focused on building trusted, lifelong customer relationships to enhance member lifetime value and retention while expanding its product offerings [1][2] - A recent survey indicates that a significant majority of Americans recognize the need for year-round insurance advisory support, with 87% valuing ongoing assistance in understanding coverage options [1][2] Group 1: New Strategy Overview - The new strategy shifts from a transaction-driven model to an ongoing relationship model, supporting consumers throughout their health journey, including Medicare and ACA plan enrollment [1] - eHealth aims to strengthen relationships with consumers by providing year-round support, conducting needs assessments, and managing plan changes proactively [1][2] Group 2: Market Insights and Consumer Needs - Survey findings reveal that 90% of Americans believe the current health insurance selection process is broken, highlighting a demand for improved support [1] - 97% of working-age Americans are interested in personalized plans tailored to their specific needs, indicating a market opportunity for customized insurance solutions [1] Group 3: Technology and Service Expansion - eHealth plans to invest in enhanced technology and integrated data systems to streamline shopping and enrollment processes, leveraging AI and advanced analytics [1] - The company intends to expand its portfolio of ancillary products and services, building on the growth achieved with Hospital Indemnity Plans in 2025 [1] Group 4: Focus on Diverse Consumer Segments - eHealth is expanding its support for consumers accessing individual coverage through employers, including Individual Coverage Health Reimbursement Arrangements (ICHRA) [1] - The strategy is expected to improve brand recognition and member retention while driving increased lifetime value [1]